Promoting the use of evidence in health policymaking in the ECOWAS region : the development and contextualization of an evidence-based policymaking guidance by Uneke, Chigozie Jesse et al.
RESEARCH Open Access
Promoting the use of evidence in health
policymaking in the ECOWAS region: the
development and contextualization of an
evidence-based policymaking guidance
Chigozie Jesse Uneke1* , Issiaka Sombie2, Ermel Johnson2, Bilikis Iyabo Uneke1 and Stanley Okolo2
Abstract
Background: The Economic Commission of the West African States (ECOWAS), through her specialised health
Institution, the West African Health Organization (WAHO) is supporting Members States to improve health
outcomes in West Africa. There is a global recognition that evidence-based health policies are vital towards
achieving continued improvement in health outcomes. The need to have a tool that will provide systematic guide
on the use of evidence in policymaking necessitated the production of the evidence-based policy-making (EBPM)
Guidance.
Methods: Google search was performed to identify existing guidance on EBPM. Lessons were drawn from the
review of identified guidance documents. Consultation, interaction and interviews were held with policymakers
from the 15 West African countries during WAHO organized regional meetings in Senegal, Nigeria, and Burkina
Faso. The purpose was to elicit their views on the strategies to promote the use of evidence in policymaking to be
included in the EBPM Guidance. A regional Guidance Validation Meeting for West African policymakers was
thereafter convened by WAHO to review findings from review of existing guidance documents and validate the
EBPM Guidance.
Results: Out of the 250 publications screened, six publications fulfilled the study inclusion criteria and were
reviewed. Among the important issues highlighted include: what evidence informed decision-making is; different
types of research methods, designs and approaches, and how to judge the quality of research. The identified main
target end users of the EBPM Guidance are policy/decision makers in the West African sub-region, at local, sub-
national, national and regional levels. Among the key recommendations included in the EBPM Guidance include:
properly defining/refining policy problem; reviewing contextual issues; initiating policy priority setting; considering
political acceptability of policy; commissioning research; use of rapid response services, use of policy advisory/
technical/steering committees; and use of policy briefs and policy dialogue.
(Continued on next page)
© The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.
* Correspondence: unekecj@yahoo.com
1African Institute for Health Policy and Health Systems, Ebonyi State
University, CAS Campus, Abakaliki PMB 053, Nigeria
Full list of author information is available at the end of the article
Uneke et al. Globalization and Health           (2020) 16:73 
https://doi.org/10.1186/s12992-020-00605-z
(Continued from previous page)
Conclusion: The EBPM Guidance is one of the emerging tools that can enhance the understanding of evidence to
policy process. The strategies to facilitate the use of evidence in policymaking outlined in the Guidance, can be
adapted to local context, and incorporated validated approaches that can be used to promote evidence-to-policy-
to-practice process in West Africa.
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Introduction
The Economic Commission of the West African States
(ECOWAS) has over the years encouraged member
states to increase investment in the health sector and
through her specialised health institution, the West Afri-
can Health Organization (WAHO) has supported the ef-
forts of members States to improve health outcomes in
the region [1]. The poor maternal and child health out-
comes in West Africa have been shown to be associated
with diverse contextual and health systems factors inher-
ent within the sub-region. These factors include, culture,
knowledge of risks and the status of women, geographic
distance of health centres, services delivery organisation,
the availability and ability of health services, and the
quality of care, and these all act together to exacerbate
the poor health outcomes in the region [1, 2]. According
to Agyepong et al. [2], the West African countries are in
dire need of increased investment in health interventions
and health systems strengthening approaches that are
evidence-based.
Currently there is a global recognition that strong and
effective health systems and health policies that are
evidence-based in their operations are vital to achieve
continued improvement in health outcomes in an effi-
cient and equitable manner [3, 4]. According to World
Health Organization (WHO), better use of evidence in
development policy making can save lives through more
effective policies that respond to scientific and techno-
logical advances, use resources more efficiently and bet-
ter meet citizens’ needs [5].
In addition to scientific evidence which typically in-
cludes research/surveys, quantitative/statistical data,
qualitative data, and analysis, evidence can also include
economic, attitudinal, behavioural and anecdotal infor-
mation, along with knowledge and opinions of experts,
as well as judgements, insight/experience, history, analo-
gies, local knowledge and culture [6]. In a previous re-
port, Bowen and Zwi [7], noted that evidence
encompasses research, and may include opinion and
views of individuals or groups, and results of consulta-
tive processes. It is therefore imperative to elicit the
views of policy actors and information gathered through
consultative engagements involving critical stakeholders
as part of evidence-to-policy process. Evidence based on
scientific research is combined with other forms of
information to provide evidence for policy development
and practice [6]. This approach can help to contextualize
the policymaking process and most likely work well in
West Africa. It has been reported that combining differ-
ent forms of evidence creates and acknowledges the con-
text within which knowledge exists and within which it
is understood [8]. Adequate combination of both scien-
tific and other forms of evidence is therefore the hall-
mark of evidence-informed decision making, a process
that must be employed if effective and result oriented
health policies are to be achieved in West Africa.
Poorly-informed decision-making is partly responsible
for the weakness of the health systems of most West Af-
rican countries [2]. In a previous report Oxman et al.
[9], noted that a poorly-informed decision-making par-
ticularly in LMICs is one of the reasons why services
sometimes fail to reach those most in need, why health
indicators become off-track and why many countries fail
to meet health targets. Nevertheless, it is important to
re-emphasize that the process of incorporating evidence
into policy making i.e. bridging the know-do-gap, is nei-
ther a simple nor straightforward venture. According to
Jones and Walsh [10], the integration of evidence into
policy decision making is a complex process of multiple,
frequently competing and/or intertwined sets of influ-
ences in which evidence plays just one of many roles.
Strydom et al. [6] reiterated that the policymaking con-
text is full of political, ideological and economic factors
that influence policy development and decision-making,
often at the expense of scientific evidence, and that
decision-makers and policymakers in many cases source
information with a particular agenda in mind.
A number of recent studies have stressed the urgent
need for increased understanding of the complexities of
the evidence to policy process among policymakers in
West Africa and also a need to have a guidance on
evidence-based policymaking [1, 2, 11]. Guidance docu-
ments with specific focus on evidence-based policy-
making or evidence-informed policymaking are
essentially scarce. However, in recent times, the need for
the production of guidance on evidence-based policy-
making is increasingly being recognized worldwide. The
process of policymaking remains very complex, necessi-
tating a step by step approach towards achieving
evidence-based policymaking. As a part of its mandate
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to promote evidence-to-policy-to practice process in
West Africa, the WAHO commissioned a project to de-
velop an adapted guide for the use of evidence in devel-
oping and implementation of health policies, plans and
protocols in the ECOWAS region. The objective of this
report is to describe the process of development and
content of the evidence-based policy-making (EBPM)
guidance designed for the promotion of the use of evi-
dence in health policymaking in West Africa.
Methods
Setting
The West African sub-region is made up of 15 countries
(Benin, Burkina Faso, Cape Verde, Cote d’Ivoire, The
Gambia, Ghana, Guinea, Guinea Bissau, Liberia, Mali,
Nigeria, Niger, Sierra Leone, Senegal and Togo). It is geo-
graphically bounded by the Atlantic Ocean in the west and
by the Gulf of Guinea in the south and is characterised by a
very rich ethnic, religious and social diversity [12]. Accord-
ing to the United Nations Development Programme report,
most of the West African countries are classified as poor
and their economies are not very well developed or diversi-
fied with the Human Development Index (HDI) rank
among the poorest in the world [13].
The West African sub-region with a population of more
than 357million (about 1/3 of entire African population) is
one of the regions in Africa with under-performing health
systems and unacceptable health outcomes [13, 14]. Many
of the West African countries are among the low-and-
middle income countries (LMICs) world-wide with the
lowest life expectancy [13]. The maternal mortality ratio
(MMR) of some of the countries in the region are among
the highest in the world. These include, Sierra Leone
(1360/100,000), Nigeria (814/100,000), Liberia (725/100,
000) and The Gambia (706/100,000) [14]. Some West Af-
rican countries record under-five mortality rates (U5MR)
which are among the highest in the world, and these in-
clude Sierra Leone (118/1000), Mali (114/1000), Nigeria
(108/1000) and Benin (100/1000) [14].
Defor et al. [15] noted that the complexity of the sub-
region are layered in traditional, ethnic, religious and
language diversity, which is further heightened by the
colonial legacy of fragmentation of the sub-region by of-
ficial language into Anglophone, Francophone and Luso-
phone. Because the complexities in the social structure
of West Africa to a large extent influence the policy-
making process in the sub-region, a policymaking guide
that will take contextual issues into consideration be-
comes imperative.
Review of previous guidance publication focusing on
evidence use in policymaking
A Google search was performed in May 2019 to identify
existing guidance on evidence-based policymaking
within the previous 20 years. The search was executed
using appropriate combination of key words such as:
guidance, guidelines, evidence-based, evidence-informed,
policymaking, decision-making, health policy. A total of
250 publications were screened using the following key
inclusion criteria: (i). must be focused on health policy-
making, (ii). must be a guidance/guideline document,
(iii). must be intended for use by policymakers/decision
makers, (iv). must outline step by step procedure for
evidence-based policymaking/decision making. Follow-
ing the screening, the publications that fulfilled the in-
clusion criteria were selected for the study.
Consultation with west African policymakers
Authors consulted and interacted with some senior
health policymakers from various West African coun-
tries. These policymakers from the 15 West African
countries were engaged into discussions and interviews
during WAHO organized regional meetings in Senegal,
Nigeria, and Burkina Faso prior to a Validation Meeting
held in Senegal in July 2019. This method has been used
successfully in previous studies to obtain information
from policymakers [16, 17]. Others were consulted via
telephone calls and email. The discussions and interview
centred on the following: (i). The necessity of the EBPM
Guidance; (ii). Intended users of the EBPM Guidance;
and (iii). Recommended strategies to promote the use of
evidence in policymaking to be included in the EBPM
Guidance. Responses from the policymakers were noted
and formed a part of the information collected and used
for the development of the Guidance.
Validation of the guidance by west African policymakers
Following the production of a draft EBPM Guidance,
both internal and external reviews were conducted by
WAHO. A revised version was produced, and thereafter
WAHO convened a Guidance Validation Meeting in July
2019 in Senegal. The objectives of the meeting were:
(i). To raise awareness on the implementation of the
regional resolution on the use of evidence.
(ii). To share the findings of the review of previous
guidance publication performed in May 2019 and find-
ings of study on the use of evidence in decision making
in West Africa.
(iii). To validate the Regional Guide on the use of evi-
dence in the ECOWAS region.
The meeting brought together heads of maternal and
child health programmes, as well as research managers
from the Ministries of Health of ECOWAS member
countries and key partners. Prior to the meeting the re-
vised EBPM Guidance was circulated to all invited par-
ticipant to study and make inputs to be discussed as the
validation meeting. During the meeting the revised
EBPM Guidance was presented and subjected to group
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work. More suggestions and recommendations for the
improvement of the Guidance were received and dis-
cussed to arrive at a consensus on the final version of
the Guidance.
Result
Description of previous guidance publications focusing
on evidence use in policymaking
Out of the 250 publications screened, six publications
fulfilled the study inclusion criteria and were reviewed.
Table 1 summarizes the characteristics of the reviewed
guidance documents on evidence-based policymaking
[18–23]. Among the important issues highlighted in-
clude: what evidence informed decision-making is; dif-
ferent types of research methods, designs and
approaches, and how to judge the quality of research;
key stages of the public policy-making process and evi-
dence use; facilitators and barriers to evidence use in
policy-making; linking evidence needs to policy prior-
ities; context of public policy-making; key stages of the
policy-making process and evidence use, and legislators
use of research evidence in public health policymaking.
Lessons were drawn and insights gained from these six
guidance/guideline documents which were used in de-
veloping the present EBPM Guidance.
Identified intended users of the guidance
The identified target end users of the EBPM Guidance
are policy/decision makers in the West African sub-
region at local, sub-national, national and regional levels.
These include elected policymakers (eg., Presidents,
Governors, members of parliament), appointed policy-
makers (e.g., Ministers, Commissioners, Directors-
General), career policymakers (e.g., Heads of depart-
ments, Programme managers, senior officials) and civil
sector policymakers (e.g., Traditional rulers, Religious
leaders, leaders of NGOs/CSOs).
Recommended strategies to promote the use of evidence
in policymaking
Following the Guidance validation meeting, the recom-
mendations received were categorized into fourteen
strategies (Table 2). These strategies were systematically
arranged to form the protocol of the EBPM Guidance.
The strategies are not necessarily chronological, but the
step-by-step implementation of the strategies will
Table 1 Characteristics of existing guidance documents on evidence-based policymaking
Author [Reference] Year of
publication
Title Target users Main focus of Guidance
Blanchet et al. [18] 2018 Using Research Evidence in




(i). What evidence informed decision-making is,
(ii). developing and implementing a new
intervention, (iii). creating a theory of change,
(iv). different types of research methods, designs




2016 Guidelines for Evidence Use
in Decision-Making in the
Health Sector
Policymakers (i). Foundation of Public Policy-Making, (ii). theory
in public policy-making, (iii). key stages of the public
policy-making process and evidence use, (iii).
characteristics of good public policy-making, (iv).
facilitators and barriers to evidence use in policy-
making,
Wills et al. [20] 2016 Guidelines and good practices
for evidence-informed policy-
making in a government
department
Policymakers (i). Using a broad definition of ‘robust evidence’, (ii).
linking evidence needs to policy priorities, (iii). linking
an evidence-informed approach with business planning,
budgeting and reporting, (iv). ensuring evidence
processes are inclusive and participatory






(i). The four elements of evidence-based management
(ii). reasons for needing evidence and creating a theory
of change, (iii). how to judge the quality of research




2015 Guidelines for evidence use in
policy-making
Policymakers (i). Context of public policy-making, (ii). key stages of
the policy-making process and evidence use, (iii).
facilitators and barriers to evidence use in policy-making,
(iv). health policy development process, accessing
evidence for policy-making
The Council of State
Governments [23]
2008 State Policy Guide:




(i). Legislators use of research evidence in public
health policymaking (ii). understanding public health
research: key facts and terms (iii). how researchers
measure success of policies and programs? (viii).
using research results in policymaking, and drafting
public health legislation
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depend on the country specific context. Participants
considered the recommendations as fundamental princi-
ples that can potentially promote evidence-to-policy
process within the West African sub-region. Participants
agreed that the EBPM Guidance be contextualized in
each country in line with the peculiarities of the
countries.
Discussion
According to Bosch-Capblanch et al. [24] and other au-
thors [25, 26], an evidence-informed health systems and
policy guidance tackles health sector problems through
the following four important strategies: (i). framing
health systems problems; (ii). systematically retrieving,
translating, and packaging the best available evidence,
(iii). using this evidence to recommend and formulate—
in a deliberative process—options to inform policy-
making; (iv). providing insights on the strategies that can
be followed in order to implement and evaluate policy.
The present EBPM Guidance was tailored in line with
these four strategies and also followed a systematic ap-
proach in its design. The EBPM Guidance is adapted to
West African contexts and was validated using standard
scientific methods, to consider all the available evidence
and to assess its quality. Local factors that may influence
the effects of all options recommended to address their
feasibility were taken into account in its development.
The production of the EBPM Guidance is largely based
on knowledge translation approaches that bridge the gap
between research evidence and its application to policy-
making [27, 28]. Consequently, the EBPM Guidance is
considered a very useful tool to decision making process,
as it incorporates the complex interrelations of the West
African health systems components, and the numerous
contextual factors that may influence the effectiveness of
policies [24].
Intended users of the EBPM guidance
The main target end users of the EBPM Guidance are
policy/decision makers in the West African sub-region
at local, sub-national, national and regional levels. These
were classified into elected policymakers, appointed pol-
icymakers, career policymakers and civil sector policy-
makers. This is consistent with a previous report by
Bammer et al. [29]. The Guidance is specifically tailored
to meet the policymaking needs of the West African pol-
icymakers. In addition to these intended users, the Guid-
ance can be of practical benefit to other persons or
groups interested in improving their knowledge and skill
in evidence informed policymaking.
Recommended strategies for the EBPM guidance
Properly define/refine the policy problem, state policy
questions
The foundation for evidence-informed policymaking is
proper definition of the policy problem or policy ques-
tion. It is important to have a clear and unambiguous
perspective of the policy objectives before moving to the
next stages of the policy development. It will certainly be
very difficult to identify the correct and relevant evi-
dence if the policy questions are not well defined. Ac-
cording to the Malawi’s Ministry of Health Guidelines
for Evidence Use in Policy-making [19], being clear on
the policy issue calls for a good understanding of where
the issue lies in the policy-making process/cycle, i.e.:
agenda-setting stage, policy formulation stage, policy im-
plementation stage, and policy evaluation stage.
Proper definition and refining of policy problems/
questions may require extensive interaction with key
Table 2 Recommended strategies for the EBPM Guidance to promote the use of evidence in policymaking for West Africa
1. Properly define/refine the policy problem, state policy questions
2. Identify and review existing similar policies
3. Review contextual issues (contextualization)
4. Initiate policy priority setting
5. Consider political acceptability of the policy
6. Access, retrieve, assess, and synthesis evidence
7. Commission research/engage researchers/ co-produce evidence and policy/ use rapid response services
8. Perform stakeholders’ analysis & Convene stakeholders’ engagement event
9. Use of policy advisory/technical/steering committees
10 Develop policy briefs and undertake policy dialogue
11. Draft the policy document
12. Subject the policy document to internal and external review
13. Ensure official endorsement of the policy by government
14. Institute monitoring, evaluation and review mechanism for the policy
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stakeholders and citizens affected (or to be affected) by
the policy issue. It may also require review of literature
and careful/objective assessment of prevailing situation
and circumstances to determine if the issue is of serious
public health concerns and merits the investment of re-
sources (time, money, man power etc) to move to other
stages of policy development.
Identify and review existing similar policies
Health policies may be developed for any one of the fol-
lowing reasons: when there is a problem or situation that
requires to be addressed and no existing policy to handle
that; when there is outdated/obsolete, harmful, unimple-
mentable or ineffective policy that requires reviewing;
and for the purpose of strengthening the implementa-
tion of a good policy to continue to generate the ex-
pected outcomes. Whatever the situation, as part of the
process of evidence-informed policymaking, it is import-
ant to identify and review existing similar policies when
embarking on policy development. The review may in-
clude similar health policies that have been developed in
other settings. Reviewing what has been done previously
is a vital step towards extracting valuable lessons for the
development of a new policy.
In conducting a review of a policy document, the fol-
lowing should be considered:
(i). Relevance of the health policy to the health
situation prevailing in the population at any point
in time.
(ii). Efficiency and effectiveness of the policy in terms of
its implementation and performance assessment.
(iii).Impact of the policy on the health outcomes and in
terms of achievement of the policy goals and
targets.
Review contextual issues (contextualization)
It is a well-established fact that policymaking is not a
linear process and does not occur in a vacuum. Every so-
ciety has its own peculiar contextual characteristics
which must be understood and taken into consideration
during policymaking. It is important to state that no ef-
fective policy can be made if contextual factors are not
taken into consideration in the policy formulation
process. Contextual factors may be environmental or
organizational.
In a recent report Peacock and Bentley [30], noted that
contextual factors such as different sources and types of
evidence used, organizational context and decision-
making structures, and the wider interests of patients,
the public and politicians can influence decision making
process. They further argued that to better understand
these influences, especially in terms of policymaking,
one needs to takes a wider view using lenses from a
range of disciplines [30]. In another recent report,
Mijumbi-Deve and Sewankambo [31] highlighted some
important contextual factors that must be taken into ac-
count in policy development process including relation-
ship between the producers or suppliers and the end
users, network effects, culture referring to the norms
and values of the environment, power (perceived and/or
actual), and high compatibility with current norms and
work processes.
Organizational contextual factors that have been found
to influence the policymaking process include internal
organizational structure – centralization, complexity,
formalization, interconnectedness, organizational slack,
and external characteristics of the organization [32]. Ac-
cording to the Guidelines for Evidence Use in Policy-
Making published by the Kenyan Ministry of Health
[22], for policymaking to be effective, civil servants in-
volved in policy development not only need all the ‘trad-
itional’ attributes (knowledge of relevant law and
practice, understanding of key stakeholders’ views, ability
to design implementation systems), but they must also
understand the context within which they (and the pol-
icy) have to work.
In a study in Ghana on the health policy agenda setting
and formulation on free antenatal care in government fa-
cilities, Koduah et al. [33], observed that contextual factors
served as bases for policymaking process and included:
political ideology, economic crisis, data about health out-
comes, historical events, social unrest, change in govern-
ment, election year, austerity measures, and international
agendas. Authors concluded that influencers of policy
agenda setting must recognize that the process is complex
and intertwined with a mix of political, evidence-based,
finance-based, path-dependent, and donor-driven pro-
cesses [33]. The contextual factors that are likely to influ-
ence a health policy in a given population must be
carefully identified and taken into consideration when de-
veloping a policy document.
Initiate policy priority setting
It is important to initiate a policy priority setting process
as a way to further establish the necessity of the develop-
ment of a particular policy. Priority-setting process has
been defined as a programme to generate consensus
about a core set of health issues that urgently require at-
tention in order to facilitate policy development [34].
Priority setting strategies in the health sector must ac-
count for the fact that resources are limited and that
trade-offs are required to decide which health conditions
deserve the most attention and which interventions
should be used to address them [35, 36]. Therefore, no
health policy development should be commenced unless
the policy to be developed is of absolute necessity. It
must be noted that the policy process is not devoid of
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competing interests and other potential causes of con-
flicts. A balanced process for setting priorities can
harmonize the competing interests, ground value sys-
tems, encourage problem-based learning, resolve con-
flict, find consensus and ultimately create a set of
agreed-upon priorities [34].
Priority setting is one of the biggest challenges faced
by policymakers in LMICs including West Africa. In low
income countries priority setting is known to be compli-
cated by the burden of underdevelopment as well as by
political instability, inadequately developed social sec-
tors, weak institutions, and marked social inequalities
[37, 38]. In order to conduct an effective policy priority
setting, it is important to take into consideration the key
contextual factors (such as the social, economic and pol-
itical factors) of relevance to priority setting, the people
or institutions involved in priority setting, the criteria or
values used in decision making and how these were
identified, the information or evidence used, and a de-
scription of the priority setting process [38].
Consider political acceptability of the policy
Policymaking can never be separated from politics. Ac-
cording to Oliver [39], science can identify solutions to
pressing public health problems, but only politics can
turn most of those solutions into reality. In a classical
report entitled: Towards a politics of health, Bambra
et al. [40] highlighted the political nature of health in
three ways:
(i). Health is political because, like any other resource or
commodity under a neo-liberal economic system,
some social groups have more of it than others.
(ii).Health is political because its social determinants
are amenable to political interventions and are
thereby dependent on political action (or more
usually, inaction).
(iii).Health is political because the right to ‘a standard of
living adequate for health and wellbeing’ (is, or
should be, an aspect of citizenship and a human
right).
There has been an increasing awareness within re-
search and policy communities that getting evidence in-
cluding research into policy is not only a technical
matter of knowledge translation and exchange, but also
a political challenge [41, 42].
According to the Alliance for Health Policy and Sys-
tems Research, policy making is a complex and essen-
tially political process that is influenced by several
factors [43]. Politics has been defined classically as who
gets what, when and how and it affects the origins, for-
mulation, and implementation of public policy in the
health sector [44]. Politics dictates the factors that affect
policymaking process, for example, who is entitled to
services, which are the priority areas, who will provide
services, who will be subsidized, and how the budget
ought to be allocated and spent [44, 45]. Consequently,
one of the first critical issues that must be taken into
cognizance in policy development is to ensure that the
policy planned has political acceptability. Glassman and
Buse [44] had earlier argued that in spite of the acknowl-
edged importance of politics in policymaking, there is
also broad agreement that politics and political issues
are rarely analyzed and frequently ignored at all stages
of the policy identification, development, and implemen-
tation process in the health sector.
Consequently, we can categorically state that any
planned health policy that fails to align with prevailing
political situation and ideology, notwithstanding the use
of the best available evidence in its development, is dead
on arrival. This is because even the best evidence is fre-
quently trumped by politics which can be the main
driver of health policy priorities and reforms [44, 46].
Politics played vital role in the success and failures of
some of the policymaking and policy implementation
processes recorded in some of the West African coun-
tries. In Benin, Dossou et al. [47] assessed user fees for
caesarean sections and observed that policy development
process suffered from inadequate uptake of evidence
largely because the policy content and process were not
completely in harmony with political goals. In Côte
d’Ivoire, Blau et al. [48] noted that a major success factor
of the National Immunization Technical Advisory Group
(NITAG) in promoting effective immunization policy
was the strong political will from the government.
Access, retrieve, assess, and synthesize evidence
After defining policy questions, reviewing contextual is-
sues, initiating policy priority setting and considering
political acceptability of the policy, the next critical step
towards evidence informed policymaking is to access
evidence. This requires knowledge of where to source
the right and relevant types of evidence. According to
Gurung, [49] evidence can come from different types of
policy research including case studies, field experiments,
secondary analysis, surveys, review of research, qualita-
tive methods, and cost benefit analysis. The major
sources of policy research include: specialized policy
unit, official statistics, think tanks, academic communi-
ties, traditional knowledge, polls, and media [49]. There
are other vital sources of evidence such as those avail-
able online such as: African Index Medicus, The
Cochrane Library, HINARI, POPLINE, PubMed, Re-
search for Life, WHO, Development Experience Clear-
inghouse (DEC), Social Systems Evidence, Health
Systems Evidence, and Campbell Collaborations [19].
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After identifying the relevant sources of evidence, the
next step is to search and retrieve the needed evidence
to be used in the policy process. In assessing the
strength of evidence, it is important to know that all evi-
dence are not of equal strength. Assessing the strength
of evidence is a challenging task, and requires the appli-
cation of technical knowledge and individual judgement
[50]. Assessment of the overall strength of a body of evi-
dence with reference to a particular policy is directly
linked to the quality, size, consistency and context of the
body of the evidence [19]. The synthesis of evidence is
very important but even more important is making use
of synthesized evidence. In this regard, Donnelly et al.
[51], outlined four principles to make evidence synthesis
more useful for policy as follows: inclusive, rigorous, ac-
cessible and transparent.
Commission research/engage researchers/ co-produce
evidence and policy/ use rapid response services
In the event of scarcity of evidence especially local or
context specific evidence, one effective way to generate
policy relevant evidence is for policymakers or the Min-
istry of Health to commission a research. Researchers
can be commissioned by the Ministry of Health to con-
duct research which will provide specific local or context
specific evidence required for the formulation of policy.
Because evidence to policy link ought to be a continuous
never-ending process, the need for policymakers to en-
gage researchers and work in partnership cannot be
overemphasized.
One of the major factors responsible for the problem
of translating research evidence into policy is the huge
gap existing between researchers and policymakers
which results in a lack of proper understanding of the
concepts and the application of evidence-informed pol-
icymaking by decision makers [52]. Uneke et al. [53]
noted that there is a dire need for partnership/collabor-
ation between researchers and policymakers in order to
(i). acquaint policymakers of evidence regularly pro-
duced by researchers and also to carry researchers along
in the policymaking process; and (ii). align researchers
more specifically to operational problems inherent in the
health systems from the policymaking perspective.
A very vital evidence to policy strategy is the engage-
ment of rapid response services (RRSs) when they are
available. RRSs are designed to receive policy and decision
questions and respond to these with the best available re-
search evidence in summarized and contextualized forms
within short periods of time, for example, less than 28
days [54]. According to Mijumbi-Deve and Sewankambo,
[31], RRSs improve the timeliness and relevance of re-
search evidence for policy-making and they are also
thought to improve contact and interaction between users
and producers of research evidence, the lack of which has
been cited as a barrier for the use of research evidence
during policy and decision-making. In Burkina Faso, the
RRSs facilitated the use of research evidence in policy-
making and largely reached the consolidation phase of the
institutionalization after project leaders, convinced policy-
makers of the importance of the service [55].
Perform stakeholders’ analysis & convene stakeholders’
engagement event
Policy actors also known as stakeholders have important
role to play in shaping evidence to policy link. To enable
the success of evidence informed policymaking, stake-
holders’ analysis (SHA) is very imperative. According to
Ruhe [56], SHA is designed to provide an organization with
information to evaluate and understand stakeholders in
term of their relevance to a policy or specific activity of the
organization. The use of SHA as a systematic technique for
gathering insights relating to a proposed policy formulation,
reform, or action is gaining increasing recognition world-
wide. This is because SHA gathers these insights by identi-
fying, categorising and analysing individuals or groups that
are likely to have a ‘stake’ (be affected by, or have an inter-
est) in a proposed policy [57–59]. SHA should identify ac-
tors who are decision-makers and as well as those impacted
by the policy issue/action being considered; essentially all
whose interests, actions and motivations influence the en-
vironment [56]. SHA has been developed to better under-
stand stakeholder power and positions around specific new
policies or actions, and assess the likely implications for the
acceptability of new policies or interventions [57].
After performing the SHA the next step is stake-
holders’ engagement. There is evidence to suggest that
stakeholder engagement is the key in both implementa-
tion and translational sciences which includes tailoring
best evidence for policy and practices for specific popu-
lations [60]. In Benin, Houngbo et al. [61], assessed gov-
ernance of healthcare technology management and
noted that interactive and analytical tools of action re-
search can be used to integrate knowledge amongst
actor groups, and that the policy development process
was characterized as bottom-up, with a central focus on
the participation of diverse stakeholders groups. In an-
other study from Benin, Lee et al. [62] while assessing
vaccine policy, observed that the enabling change re-
quired identifying in-country “champions,” and orches-
tration of a coordinated set of steps that heavily involve
key stakeholders. In Cape Verde, Nabyonga-Orem et al.
[63] assessed health policy dialogue and observed that
ensuring stakeholder participation, improving stake-
holder harmonization and alignment, providing a guid-
ing framework and facilitating stakeholder analysis in
policy dialogue offered the opportunity to improve
stakeholder participation in policy development and pro-
mote aid effectiveness.
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Use of policy advisory/technical/steering committees
The use of policy advisory/technical/steering committees
in promoting evidence to policy process is well estab-
lished. This mechanism is recommended for use to West
African policymakers because of the numerous positive
outcomes reported across the sub-region. In Nigeria,
Uneke et al. [64] assessed the role of a health policy advis-
ory committee (HPAC) in bridging the divide between re-
search and policy. The HPAC can function as a health
coordination mechanism designed to standardize and de-
velop a sector wide approach in the development of
evidence-informed health policy and the strategies for im-
plementation [64–66].
Other recommended mechanisms similar to the HPAC
which are capable of facilitating evidence to policy process
are policy technical groups and policy steering commit-
tees. In Côte d’Ivoire, Blau et al. [48] described the tre-
mendous success a National Immunization Technical
Advisory Group (NITAG) achieved in promoting evidence
to policy process regarding immunization and vaccines.
Similarly, in Ghana, Howard et al. [67] examined the func-
tionality of NITAG and noted that the NITAGs had an
important and valued role within national immunization
decision-making. In Burkina Faso, Keita et al. [68] assessed
the role of steering committees (SCs) in the promotion of
evidence to policy process and observed that SCs provided
technical assistance to researchers during the implementa-
tion phase and facilitated the transfer and use of the
findings.
Develop policy briefs and undertake policy dialogue
The use of policy briefs and policy dialogues are major
strategies of achieving evidence to policy link. In Nigeria
policy briefs and policy dialogues have been used to pro-
mote evidence informed policymaking [69, 70]. Lavis
et al. [71], noted that policy brief is an effective
evidence-packaging mechanism and a new approach to
improving the policy-making process by supporting
evidence-informed policy-making.
The use of policy briefs and policy dialogues has been
reported in many parts of West Africa as effective mech-
anisms that greatly promoted the evidence to policy link.
In Ghana, Araujo de Carvalho et al. [72] reported that
policy briefs were developed and were used to define pri-
ority problems and health system responses to ageing
and health. In Cape Verde, Nabyonga-Orem et al. [63]
observed that policy dialogue offered the opportunity to
improve stakeholder participation in policy development
and promoted aid effectiveness. In a second study from
Cape Verde, Dovlo et al. [73] noted that policy dialogues
have proved to be an effective tool in health sector man-
agement and could be a crucial component of the gov-
ernance dynamics of the sector. They highlighted the
dialogue success factors to included: the use of
innovative approaches, good facilitation, availability of
resources for dialogues, good communication, and con-
sideration of different opinions [73]. In Guinea, Kwamie
and Nabyonga-Orem [74], while assessing the role of policy
dialogue in evidence-informed policymaking, noted that
policy dialogue improves harmonization in terms of foster-
ing information exchange amongst partners.
Draft the health policy document
In drafting the policy document, it is important to keep
the language simple and strait forward without losing
the intent of the policy. Unnecessary jargons must be
avoided with the understanding that many readers of the
policy documents may not be specialists in the health is-
sues the policy is addressing.
Subject the policy document to internal and external review
After drafting the policy, it is very important for the
draft to be subjected to both internal and external com-
prehensive review process. The purpose of a comprehen-
sive review is to take an in-depth look at the draft policy
to: (i). determine if the policy is still needed or if it
should be combined with another policy; (ii). determine
whether the purpose and goal of the policy is achievable;
(iii) determine if changes are required to improve the ef-
fectiveness or clarity of the policy; and (iv). to ensure
that appropriate monitoring and evaluation mechanism
is integrated into the policy [75]. The reviewers should
be experts or specialists in the policy specific area and
should include senior policymakers, senior researchers
and senior practitioners.
Ensure official endorsement of the policy by government
Aligning the policymaking process with the govern-
ment’s policy direction/agenda is one of the best ways to
guarantee that the government in power will support
and endorse the policy. There is no hope for an anti-
government policy. No policy is likely to succeed to the
implementation stages if it does not receive govern-
ment’s endorsement. The following are four practical
strategies that can be taken to facilitate government en-
dorsement of a policy: (i). align the policy with the
mandate and priority of the government in power; (ii).
engage the leaders of ruling political party as champions
of the policy development process; (iii). involve relevant
government apparatus in all stages of the policy develop-
ment; (iv). employ the process of lobbying of very influ-
ential persons in the government to drive the policy
process.
Political parties the world-over are known to have
strong influence on policies and policymaking process.
Normally, every party has its manifesto and ideologies
and these are brought into governance if the party gains
power. It is important for the leaders of the political
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parties to be engaged in policymaking process as this
strategy is likely to facilitate the policy endorsement by
government of that political party. There are numerous
studies that have shown that party orientation has a
strong influence of policy making process and imple-
mentation [76–79].
Institute monitoring, evaluation and review mechanism for
the policy
There is a dearth of studies focussing on policy monitor-
ing, evaluation and reviews. Policy monitoring, evalu-
ation and review are critical components of the
evidence-informed policymaking. Every policy that is
made has set objectives and desired goals or outcomes.
Monitoring, evaluation and review are essential func-
tions to ensure that the priority health actions outlined
in the policy documents are implemented as planned
against stated objectives and desired results [80].
To ensure that policies meet up to international best
practice standard, they should have life span so as to ne-
cessitate policy review towards the expiration date. Also,
regular monitoring, evaluation and review mechanism
must be incorporated into the policy. According to
WHO [81], regular monitoring and evaluation system is
required in order to ensure that indicators are measuring
what they are meant to, that data are generated accord-
ing to standards, that data analysis and communication
of results give the information needed by decision-
makers. The main components of policy monitoring and
evaluation platform include sound policy and institu-
tional environment; well-functioning data sources;
strong institutional capacity for data collection, manage-
ment, analysis, use and dissemination; and effective
country mechanisms for review and action [80].
Conclusion
The production of the EBPM Guidance is a reflection of
the WAHO resolve to promote evidence to policy link
in the West African sub-region. Although the knowledge
of evidence-informed policymaking is not yet wide
spread among policymakers in West Africa, the under-
standing of the process is being vigorously promoted in
the region. The EBPM Guidance is one of the emerging
tools designed to enhance the understanding of evidence
to policy process in West Africa. The strategies to facili-
tate the use of evidence in policymaking outlined in the
Guidance, can be adapted to local context, and incorpo-
rated validated approaches that can be used to consider
available evidence and its quality. These attributes are
reported by Bosch-Capblanch et al. [24], as very vital for
an ideal guidance for evidence-informed policies about
health systems in any low-income setting.
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